United States· US:0904-6834_f6d603f8-d4ee-4541-928a-eb81b26bd4db

Flucytosine

A flucytosine product containing flucytosine, registered in United States by Major Pharmaceuticals. The same ATC class is registered in 8 of our 19 countries.

ATC J02AX01US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedFlucytosineATCJ02AX01REGISTER NO.US:0904-6834_f6d603f8…PACKS LISTED2CHECKEDSeptember 27, 2026

Where it is registered

Flucytosine is registered in 8 of 19 countries.

Countries holding a registration under ATC J02AX01 (flucytosine), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 5 of them publish a price we can compare per daily dose

Flucytosine · ATC J02AX01

8 / 19 countries

  • Czechiaprice
  • Finlandprice
  • Germany
  • Netherlands
  • Norwayprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of flucytosine costs, country by country.

Normalised to the WHO defined daily dose (10 g), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Flucytosine · price per daily dose (10 g)

USD · FX 28 Sept 2026

  • FR France$11.41
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
FLUCYTOSINE
Manufacturer
Major Pharmaceuticals
Country
United States (US)
ATC code
J02AX01
ATC class
Flucytosine
Defined daily dose
10 g, O
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 2

  • ndc11
    0904683407
    30 BLISTER PACK in 1 CARTON (0904-6834-07) / 1 CAPSULE in 1 BLISTER PACK
  • ndc11
    0904-6834-07

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

99 interactions on record for flucytosine.

Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Flucytosine · interactions on record

99 records

  • 4 severe
  • 93 moderate
  • 1 minor

Most severe, free to view

  • CladribineL01BB04severe
  • CladribineL04AA40severe
  • ClozapineN05AH02severe
  • DeferiproneV03AC02severe

1 more interaction with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Flucytosine in 7 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All flucytosine products

Authorised across Europe · EMA

The same active substance is authorised in 7 EEA countries. Names it is sold under:

  • Austria · Ancotil
  • Germany · Ancotil
  • France · Ancotil
  • United Kingdom (Northern Ireland) · Ancotil
  • Italy · Ancotil
  • Netherlands · Ancotil
  • Sweden · Ancotil

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/da0d7952-07df-4c56-85d3-85a59ea9f2a7
GET /v1/drugs/da0d7952-07df-4c56-85d3-85a59ea9f2a7?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "250",
  "substance": "FLUCYTOSINE",
  "productndc": "0904-6834",
  "dosage_form": "CAPSULE",
  "dea_schedule": null,
  "strength_unit": "mg/1",
  "application_number": "ANDA204652",
  "marketing_category": "ANDA"
}

See everything about flucytosine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.